• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Abbott updates FreeStyle Libre 2 app with silent alarm mode

October 11, 2023 By Sean Whooley

Abbott FreeStyle Libre 2
The FreeStyle Libre 2 continuous glucose monitor (CGM). [Image from Abbott]
Abbott (NYSE:ABT) announced today that it released a new FreeStyle Libre 2 app version with fully customizable alarms.

The updated app release for the Abbott continuous glucose monitor (CGM) system — version 2.7.5 — features silent mode. This enables people with diabetes to use their CGM with less interruptions throughout the day.

Silent mode delivers signal loss and glucose alarms without sound or vibration for up to six hours in five-minute increments. While in silent mode, visual notifications still appear on the smartphone’s lock screen, so users can view them at their convenience.

According to an Abbott spokesperson, silent mode applies to alarms for urgent low glucose, low glucose, high glucose and signal loss.

“We designed the FreeStyle Libre family of products to be easy and convenient,” said Jared Watkin, SVP for Abbott’s diabetes care business. “As we’ve learned more about how our customers use the technology, we’ve discovered that they want more control over their alarm settings to lessen noise or vibration throughout the day. Our latest FreeStyle Libre 2 app includes a new Silent Mode, so people can receive optional, real-time glucose alarms when it’s suitable for them.”

The news marks another positive development for Abbott’s previous-generation CGM. While the company has the next-generation FreeStyle Libre 3 available, it’s looked to provide a series of updates for those who still use FreeStyle Libre 2.

Two recent examples include integration updates with automated insulin delivery and health platforms. In June, Insulet shared news that it was progressing with the integration of its Omnipod 5 automated insulin delivery system with FreeStyle Libre 2. Then, last month, Abbott shared that it made available a connected app for people with diabetes to manage their health in collaboration with WeightWatchers.

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: abbott

IN CASE YOU MISSED IT

  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor
  • Mosanna launches with $80M to support nasal spray for obstructive sleep apnea

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS